Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients

Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients

IntroductionSurvival rates in patients with non-medullary thyroid carcinoma (NMTC) are high, increasing the possibility to develop a second malignant neoplasm (SMN). Many studies investigated the relationship between increased risk of SMN in NMTC patients treated with radioiodine, but few data are a...

Full description

Bibliographic Details
Main Authors: Marco Capezzone, Alfonso Sagnella, Silvia Cantara, Noemi Fralassi, Fabio Maino, Raffaella Forleo, Lucia Brilli, Tania Pilli, Alessandra Cartocci, Maria Grazia Castagna
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Endocrinology
Subjects:
thyroid cancer
second malignant neoplasm
sporadic NMTC
familial NMTC
differentiated thyroid cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.845954/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.845954/full

Similar Items